Structure Therapeutics Inc.GPCR stock score: 29/100

$17.12 · -1.38% · Scored Nov 19, 2026

Technical
20
Fundamental
31
News
52

The reading

Structure Therapeutics (GPCR) scores 29 out of 100, which reads bearish, higher than 3% of Healthcare stocks and 4% of the 4,118 US stocks we score.

The composite weights fundamentals 80% and technicals 20%: fundamentals read 31, technicals 20.

Among the fundamentals, Quick Ratio at 100 and Price Target at 100 score highest, while Earnings Growth (Annual) at 1 weighs the most against it.

On the daily chart, trend-following indicators average 11 and contrarian oscillators 69 — a split worth reading before trusting the technical total.

News sentiment is neutral at 52; it is shown, not counted in the composite.

Since Aug 22, 2026 the composite has ranged from 28 to 47, and it is down 15 points over the period.

About Structure Therapeutics

Structure Therapeutics (GPCR) is a clinical-stage biopharmaceutical company that designs oral small-molecule drugs aimed at G-protein-coupled receptors, a large family of drug targets. It uses structural biology and computational chemistry to design pills that act on receptors usually targeted by injected peptide drugs. Its lead candidate, aleniglipron, is a once-daily oral GLP-1 receptor agonist for obesity, which produced meaningful weight loss in mid-stage trials and is moving into late-stage studies. Because it is a small molecule rather than a peptide, it may be cheaper to produce at large scale and does not need injections or fasting rules. The company is also developing oral amylin receptor agonists and other metabolic candidates. Structure has operations in South San Francisco and Shanghai, has no product revenue and funds research with cash raised from investors.

Structure competes with Eli Lilly and Novo Nordisk, which sell injectable obesity drugs and are developing or selling oral options, and with Roche, AstraZeneca, Viking Therapeutics and other developers of oral weight-loss drugs. Its edge rests on structure-based drug design, a small-molecule approach suited to mass production and data showing weight loss comparable with some injectable drugs. Investors who follow GPCR stock tend to watch the start and progress of late-stage aleniglipron trials. Tolerability findings, partnering interest and data from amylin programs are closely followed. Cash runway and competition in oral obesity drugs are other factors.

What’s driving the score

The strongest and weakest of the scorers that count toward GPCR’s composite. Each returns 0–100, higher is more bullish — including metrics where low is good, like P/E.

Fundamental

31

Pulling it up

  • Quick ratio measures a company's ability to meet short-term obligations with liquid assets.

  • Price target score compares the current stock price to analyst consensus targets.

  • Current assets divided by current liabilities: the ability to pay short-term bills.

Holding it back

26 weighted scorers; 13 had no data today and are left out rather than counted as zero.

Technical · daily

18

Pulling it up

  • Bollinger Bands (20-period) plot standard deviations above and below a moving average.

  • Relative Strength Index (14-period) measures momentum by comparing recent gains to losses.

  • Williams %R (28-period) places the close within the last 28 periods' high-low range.

Holding it back

  • S&P 500 52-week comparison evaluates the stock's annual performance relative to the broader market.

  • Where the price sits between its 52-week low and high.

  • Performance versus SPY compares the stock's returns to the S&P 500 index.

61 weighted scorers; 4 had no data today and are left out rather than counted as zero.

News · shown, not counted

Global News
52

Technical score by timeframe

ChartScoreWeight
Hourly311
Daily183
Weekly172

Composite score, last 90 days

05010029Aug 22, 2026Nov 19, 2026Aug 22, 2026: 44Aug 23, 2026: 45Aug 24, 2026: 44Aug 25, 2026: 47Aug 26, 2026: 46Aug 27, 2026: 46Aug 28, 2026: 43Aug 29, 2026: 44Aug 30, 2026: 44Aug 31, 2026: 41Sep 1, 2026: 46Sep 2, 2026: 46Sep 3, 2026: 44Sep 4, 2026: 44Sep 5, 2026: 45Sep 6, 2026: 45Sep 7, 2026: 45Sep 8, 2026: 41Sep 9, 2026: 40Sep 10, 2026: 38Sep 11, 2026: 38Sep 12, 2026: 38Sep 13, 2026: 38Sep 14, 2026: 38Sep 15, 2026: 39Sep 16, 2026: 35Sep 17, 2026: 37Sep 18, 2026: 37Sep 19, 2026: 37Sep 20, 2026: 37Sep 21, 2026: 39Sep 22, 2026: 39Sep 23, 2026: 38Sep 24, 2026: 39Sep 25, 2026: 39Sep 26, 2026: 38Sep 27, 2026: 38Sep 28, 2026: 37Sep 29, 2026: 35Sep 30, 2026: 34Oct 1, 2026: 34Oct 2, 2026: 33Oct 3, 2026: 32Oct 4, 2026: 33Oct 5, 2026: 34Oct 6, 2026: 34Oct 7, 2026: 34Oct 8, 2026: 33Oct 9, 2026: 33Oct 10, 2026: 33Oct 11, 2026: 33Oct 12, 2026: 32Oct 13, 2026: 32Oct 14, 2026: 32Oct 15, 2026: 33Oct 16, 2026: 32Oct 17, 2026: 33Oct 18, 2026: 33Oct 19, 2026: 34Oct 20, 2026: 35Oct 21, 2026: 34Oct 22, 2026: 33Oct 23, 2026: 31Oct 24, 2026: 33Oct 25, 2026: 33Oct 26, 2026: 32Oct 27, 2026: 33Oct 28, 2026: 32Oct 29, 2026: 34Oct 30, 2026: 33Oct 31, 2026: 34Nov 1, 2026: 34Nov 2, 2026: 32Nov 3, 2026: 31Nov 4, 2026: 32Nov 5, 2026: 30Nov 6, 2026: 32Nov 7, 2026: 32Nov 8, 2026: 32Nov 10, 2026: 34Nov 11, 2026: 33Nov 12, 2026: 28Nov 13, 2026: 30Nov 14, 2026: 30Nov 15, 2026: 30Nov 16, 2026: 29Nov 17, 2026: 29Nov 18, 2026: 29Nov 19, 2026: 29
Show the daily numbers
DateComposite
Nov 19, 202629
Nov 18, 202629
Nov 17, 202629
Nov 16, 202629
Nov 15, 202630
Nov 14, 202630
Nov 13, 202630
Nov 12, 202628
Nov 11, 202633
Nov 10, 202634
Nov 8, 202632
Nov 7, 202632
Nov 6, 202632
Nov 5, 202630
Nov 4, 202632
Nov 3, 202631
Nov 2, 202632
Nov 1, 202634
Oct 31, 202634
Oct 30, 202633
Oct 29, 202634
Oct 28, 202632
Oct 27, 202633
Oct 26, 202632
Oct 25, 202633
Oct 24, 202633
Oct 23, 202631
Oct 22, 202633
Oct 21, 202634
Oct 20, 202635
Oct 19, 202634
Oct 18, 202633
Oct 17, 202633
Oct 16, 202632
Oct 15, 202633
Oct 14, 202632
Oct 13, 202632
Oct 12, 202632
Oct 11, 202633
Oct 10, 202633
Oct 9, 202633
Oct 8, 202633
Oct 7, 202634
Oct 6, 202634
Oct 5, 202634
Oct 4, 202633
Oct 3, 202632
Oct 2, 202633
Oct 1, 202634
Sep 30, 202634
Sep 29, 202635
Sep 28, 202637
Sep 27, 202638
Sep 26, 202638
Sep 25, 202639
Sep 24, 202639
Sep 23, 202638
Sep 22, 202639
Sep 21, 202639
Sep 20, 202637
Sep 19, 202637
Sep 18, 202637
Sep 17, 202637
Sep 16, 202635
Sep 15, 202639
Sep 14, 202638
Sep 13, 202638
Sep 12, 202638
Sep 11, 202638
Sep 10, 202638
Sep 9, 202640
Sep 8, 202641
Sep 7, 202645
Sep 6, 202645
Sep 5, 202645
Sep 4, 202644
Sep 3, 202644
Sep 2, 202646
Sep 1, 202646
Aug 31, 202641
Aug 30, 202644
Aug 29, 202644
Aug 28, 202643
Aug 27, 202646
Aug 26, 202646
Aug 25, 202647
Aug 24, 202644
Aug 23, 202645
Aug 22, 202644

Key facts

Market cap
$1.2B
Sector
Healthcare
Industry
Biotechnology
Beta
-1.20
Risk grade (1–10)
—
Next earnings
Nov 9, 2026

Questions

What is GPCR's stock rating today?

GPCR scores 29/100 (Bearish) as of Nov 19, 2026: technical 20, fundamental 31, and news sentiment 52, which is shown but not counted. Scores are recomputed every night.

What does Structure Therapeutics do?

Structure Therapeutics (GPCR) is a clinical-stage biopharmaceutical company that designs oral small-molecule drugs aimed at G-protein-coupled receptors, a large family of drug targets. It uses structural biology and computational chemistry to design pills that act on receptors usually targeted by injected peptide drugs.

Is GPCR stock a buy?

The score is not a buy or sell recommendation. A 29 says the technical and fundamental signals we measure lean bearish today, relative to every other stock scored the same way. Use the breakdown above to see why, and treat it as a starting point for your own research.

How is the GPCR score calculated?

87 weighted scorers feed it today: 26 fundamental, scored against Healthcare ranges, and 61 technical on the daily chart, with 3 timeframes blended into the technical total. Every scorer returns 0–100; missing data is left out, never counted as zero.

Scores are information, not investment advice. Computed from Yahoo Finance, Finnhub and Alpha Vantage data; technical indicators via TA-Lib. Past scores do not predict future returns.

Embed this score

A badge for a blog post, newsletter or README. It updates every night and links back here. More badges

GPCR stock score

HTML

<a href="https://stocksscores.com/stocks/gpcr/"><img src="https://stocksscores.com/stocks/gpcr/badge.svg" alt="GPCR stock score" height="20"></a>

Markdown

[![GPCR stock score](https://stocksscores.com/stocks/gpcr/badge.svg)](https://stocksscores.com/stocks/gpcr/)